Vaccine and treatment evaluation units (VTEU) protocol development, implementation and assays task area B-D phase 1 PK trial to evaluate fosfomycin task order 16-0058.B1C1D1.0076
Ended Awarded Last action
- Contract number
- HHSN27200022
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,222,392
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2012144 Solicitation number
- Vaccine and treatment evaluation units (VTEU) Award Notice · Posted Mar 29, 2012
- Contract value 100% obligated
- $1,222,392.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27705, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $31,500 | |
| Supplemental Agreement for work within scope | $29,154 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $45,023 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,116,715 |
About this award
This contract was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Duke University Office of Research Administration Division. The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which focuses on developing and evaluating vaccines and treatments. This specific task order, valued at $1,222,392.00, is for protocol development, implementation, and assays for a Phase 1 pharmacokinetic trial to evaluate the antibiotic fosfomycin. The contract is a delivery order with a cost-no-fee pricing type and a completion date of October 31, 2023. No set-aside designation was used for this award. As a private research university, Duke University has extensive experience conducting clinical research and providing immunization safety assessment services under federal contracts and grants.
Quick answers
Who was awarded contract HHSN27200022?
HHSN27200022 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 17, 2017.
How much is contract HHSN27200022 worth?
The government has obligated $1,222,392 on HHSN27200022.
Is contract HHSN27200022 an order under another contract?
Yes. HHSN27200022 is a delivery order under HHSN272201300017I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).
Was contract HHSN27200022 competed?
The extent of competition for HHSN27200022 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award